John A. Gallien, PhD, MS

Media Releases

Get to know Neuroscientist Dr. John A. Gallien, who serves patients in California.

Dr. Gallien, a highly-trained neuroscientist, is a Postdoctoral Scholar in the Department of Cell and Tissue Biology at the University of California San Francisco.

“From genomics and immunology to specialty care for women and children, UCSF brings together the world’s leading experts in nearly every area of health. We are home to five Nobel laureates who have advanced the understanding of cancer, neurodegenerative diseases, aging and stem cells. Our hospitals and educational programs consistently rank among the best in the country, according to the latest surveys by U.S. News & World Report” as stated on their website. 

Schooled in the United States, Dr. Gallien graduated with his Bachelor of Arts degree from San Diego State University in 2012. He then went on to earn his Master of Science degree from the University of Texas at Tyler in 2016, his Master of Science degree from Central Michigan University in 2018, and his Doctor of Philosophy degree in Neuroscience from Central Michigan University in 2021.

Furthering his training, he served as an intern at Martin Neurobehavioral Center, a clinical graduate fellowship at Michigan Leadership Education in Neurodevelopmental and Related Disabilities, and as both a graduate teaching assistant and graduate research assistant at Central Michigan University.

Staying up to date in his field, Dr. Gallien is an active member of the Society for Neuroscience, the National Academy of Neuropsychology, the American Psychological Association, and the National Society of Leadership and Success. 

His areas of research include glioblastoma, adenoid cystic carcinoma, pancreatic cancer, Huntington’s disease, Alzheimer’s disease, ischemic stroke, and polyamidoamine dendrimers.

A neuroscientist (or neurobiologist) is a scientist who has specialized knowledge in neuroscience, a branch of biology that deals with the physiology, biochemistry, psychology, anatomy and molecular biology of neurons, neural circuits, and glial cells and especially their behavioral, biological, and psychological aspect in health and disease.

Among his philanthropic endeavors, Dr. Gallien is involved with Shriners Hospitals for Children and Toys for Tots. 

As he proceeded through 8 years of graduate school and onto his postdoctoral fellowship, he attributes his success to the unconditional support of his family.

Recommended Articles

• Woman with Multiple Sclerosis Lives Her Dream

  When a person is first diagnosed with a chronic, progressive condition like multiple sclerosis, it can be hard to look ahead to the rest of life and have a positive outlook. Moving forward in life and adapting to the change is that much more difficult with the knowledge that the condition will cause...

• Everest to End Duchenne: A Journey Against Duchenne Muscular Dystrophy

  Latest research on Duchenne Muscular Dystrophy (usually abbreviated as DMD) have been actively pursuing different, exciting strategies and methods. Some of the most renowned ones that have been tested on humans in clinical trials recently are: gene repair, gene therapy and exon skipping. This...

• The Link Between Concussions and Multiple Sclerosis

  In today’s world, we are told that ‘if an individual has experienced a severe jolt or blow to the head, which has left them dazed, confused, or wobbly - they have concussion”. (Medical News Today: MNT)According to Christian Nordqvist, a writer for MNT, a concussion causes a temporary loss of...

• See How This Police Department Is Trained to Interact with Alzheimer's Patients

  In Little Rock, Arkansas, a police department has added a little more training when handling Alzheimer's patients. In the communities that surround this police department, there are up to 60,000 cases of Alzheimer's disease that have been reported. Because of this training, the Little Rock Police...

• Protein Interactions May Help Explain Memory Loss with Parkinson's

  Up until recently, scientists only knew that as Parkinson’s disease progresses so do all of its symptoms, particularly around memory loss.  They also knew that as many as 30% of Parkinson’s sufferers develop dementia.  What they didn’t know was why or, really how they treat it in...

• New Machine Could Detect Early Alzheimer's

  A group of biomedical researchers from Case Western Reserve University may have found a new and better way to catch early Alzheimer’s.Why catch Alzheimer’s early?Alzheimer’s affects about 5.5 million Americans, and as people are getting older and living longer, anyone can expect that this...